This is not the most recent version of the article. View current version (26 JUN 2016)

Intervention Review

Aripiprazole for autism spectrum disorders (ASD)

  1. Heidi Ching1,
  2. Tamara Pringsheim2,*

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 16 MAY 2012

Assessed as up-to-date: 4 NOV 2011

DOI: 10.1002/14651858.CD009043.pub2


How to Cite

Ching H, Pringsheim T. Aripiprazole for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No.: CD009043. DOI: 10.1002/14651858.CD009043.pub2.

Author Information

  1. 1

    Albany Medical College, Albany, NY, USA

  2. 2

    University of Calgary, Clinical Assistant Professor, Department of Clinical Neurosciences and Pediatrics, Calgary, Alberta, Canada

*Tamara Pringsheim, Clinical Assistant Professor, Department of Clinical Neurosciences and Pediatrics, University of Calgary, Alberta Children's Hospital, C4-431, 2888 Shaganappi Trail NW, Calgary, Alberta, T3B 6A8, Canada. tmprings@ucalgary.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 16 MAY 2012

SEARCH

This is not the most recent version of the article. View current version (26 JUN 2016)

  1. You have free access to this content

    Current Version

    Aripiprazole for autism spectrum disorders (ASD)

    Lauren E Hirsch and Tamara Pringsheim

    Version of Record online: 26 JUN 2016 | DOI: 10.1002/14651858.CD009043.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Aripiprazole for autism spectrum disorders (ASD)

    Heidi Ching and Tamara Pringsheim

    Version of Record online: 16 MAY 2012 | DOI: 10.1002/14651858.CD009043.pub2

  2. Version 1

    Aripiprazole for Autism Spectrum Disorders (ASD)

    Heidi Ching and Tamara Pringsheim

    Version of Record online: 16 MAR 2011 | DOI: 10.1002/14651858.CD009043